The development and testing of a new communication tool to help clinicians inform patients with obstructive sleep apnoea syndrome about treatment options: a decision aid for the treatment of sleep apnoea

Nathalie Pelletier-Fleury, Amiram Gafni, Nicolas Krucien, Bernard Fleury

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The objective of this study was to develop a tool to help clinicians inform patients about mechanical treatment options, continuous positive airway pressure and oral appliances for obstructive sleep apnoea syndrome, and to assess its validity, reliability and acceptability. Continuous positive airway pressure is always indicated as a first-line treatment in patients with severe obstructive sleep apnoea syndrome. However, oral appliances
might be an effective treatment option in patients who fail
treatment attempts, and also as a first-line treatment for patients with mild to moderate obstructive sleep apnoea. To help patients choose their initial treatment, we developed an electronic decision board to present information regarding the potential benefits and side effects of the two treatment options, using the best available evidence. In 34 healthy volunteers, to test validity we evaluated the extent to which the respondents preferences for a treatment changed predictably when the rate of effectiveness and side effects were modified. Reliability was tested by re-administering the decision board 2 weeks afterwards (kappa test). The decision-board acceptability was evaluated in 99 consecutive patients newly diagnosed with obstructive sleep apnoea syndrome. We
found that the decision board was valid. Reliability was excellent
(j = 0.94). Concerning acceptability, 72% of the patients were satisfied with the information provided in the decision board and 71% indicated that it helped them to make a decision. The average score of true ⁄ false test of knowledge was 7.9 of 10 (range 3–10). The decision board we developed is a valid, reliable and acceptable tool to assess patients preferences.
Original languageEnglish
Pages (from-to)577–583
Number of pages7
JournalJournal of Sleep Research
Volume21
Issue number5
Early online date29 Mar 2012
DOIs
Publication statusPublished - Oct 2012

Fingerprint

Decision Support Techniques
Sleep Apnea Syndromes
Obstructive Sleep Apnea
Communication
Continuous Positive Airway Pressure
Therapeutics
Patient Preference
Reproducibility of Results
Healthy Volunteers

Cite this

The development and testing of a new communication tool to help clinicians inform patients with obstructive sleep apnoea syndrome about treatment options : a decision aid for the treatment of sleep apnoea. / Pelletier-Fleury, Nathalie; Gafni, Amiram; Krucien, Nicolas; Fleury, Bernard.

In: Journal of Sleep Research, Vol. 21, No. 5, 10.2012, p. 577–583.

Research output: Contribution to journalArticle

@article{fcf9e21f8a014eb3b837ddd44919e1b1,
title = "The development and testing of a new communication tool to help clinicians inform patients with obstructive sleep apnoea syndrome about treatment options: a decision aid for the treatment of sleep apnoea",
abstract = "The objective of this study was to develop a tool to help clinicians inform patients about mechanical treatment options, continuous positive airway pressure and oral appliances for obstructive sleep apnoea syndrome, and to assess its validity, reliability and acceptability. Continuous positive airway pressure is always indicated as a first-line treatment in patients with severe obstructive sleep apnoea syndrome. However, oral appliancesmight be an effective treatment option in patients who failtreatment attempts, and also as a first-line treatment for patients with mild to moderate obstructive sleep apnoea. To help patients choose their initial treatment, we developed an electronic decision board to present information regarding the potential benefits and side effects of the two treatment options, using the best available evidence. In 34 healthy volunteers, to test validity we evaluated the extent to which the respondents preferences for a treatment changed predictably when the rate of effectiveness and side effects were modified. Reliability was tested by re-administering the decision board 2 weeks afterwards (kappa test). The decision-board acceptability was evaluated in 99 consecutive patients newly diagnosed with obstructive sleep apnoea syndrome. Wefound that the decision board was valid. Reliability was excellent(j = 0.94). Concerning acceptability, 72{\%} of the patients were satisfied with the information provided in the decision board and 71{\%} indicated that it helped them to make a decision. The average score of true ⁄ false test of knowledge was 7.9 of 10 (range 3–10). The decision board we developed is a valid, reliable and acceptable tool to assess patients preferences.",
author = "Nathalie Pelletier-Fleury and Amiram Gafni and Nicolas Krucien and Bernard Fleury",
year = "2012",
month = "10",
doi = "10.1111/j.1365-2869.2012.01015.x",
language = "English",
volume = "21",
pages = "577–583",
journal = "Journal of Sleep Research",
issn = "0962-1105",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - The development and testing of a new communication tool to help clinicians inform patients with obstructive sleep apnoea syndrome about treatment options

T2 - a decision aid for the treatment of sleep apnoea

AU - Pelletier-Fleury, Nathalie

AU - Gafni, Amiram

AU - Krucien, Nicolas

AU - Fleury, Bernard

PY - 2012/10

Y1 - 2012/10

N2 - The objective of this study was to develop a tool to help clinicians inform patients about mechanical treatment options, continuous positive airway pressure and oral appliances for obstructive sleep apnoea syndrome, and to assess its validity, reliability and acceptability. Continuous positive airway pressure is always indicated as a first-line treatment in patients with severe obstructive sleep apnoea syndrome. However, oral appliancesmight be an effective treatment option in patients who failtreatment attempts, and also as a first-line treatment for patients with mild to moderate obstructive sleep apnoea. To help patients choose their initial treatment, we developed an electronic decision board to present information regarding the potential benefits and side effects of the two treatment options, using the best available evidence. In 34 healthy volunteers, to test validity we evaluated the extent to which the respondents preferences for a treatment changed predictably when the rate of effectiveness and side effects were modified. Reliability was tested by re-administering the decision board 2 weeks afterwards (kappa test). The decision-board acceptability was evaluated in 99 consecutive patients newly diagnosed with obstructive sleep apnoea syndrome. Wefound that the decision board was valid. Reliability was excellent(j = 0.94). Concerning acceptability, 72% of the patients were satisfied with the information provided in the decision board and 71% indicated that it helped them to make a decision. The average score of true ⁄ false test of knowledge was 7.9 of 10 (range 3–10). The decision board we developed is a valid, reliable and acceptable tool to assess patients preferences.

AB - The objective of this study was to develop a tool to help clinicians inform patients about mechanical treatment options, continuous positive airway pressure and oral appliances for obstructive sleep apnoea syndrome, and to assess its validity, reliability and acceptability. Continuous positive airway pressure is always indicated as a first-line treatment in patients with severe obstructive sleep apnoea syndrome. However, oral appliancesmight be an effective treatment option in patients who failtreatment attempts, and also as a first-line treatment for patients with mild to moderate obstructive sleep apnoea. To help patients choose their initial treatment, we developed an electronic decision board to present information regarding the potential benefits and side effects of the two treatment options, using the best available evidence. In 34 healthy volunteers, to test validity we evaluated the extent to which the respondents preferences for a treatment changed predictably when the rate of effectiveness and side effects were modified. Reliability was tested by re-administering the decision board 2 weeks afterwards (kappa test). The decision-board acceptability was evaluated in 99 consecutive patients newly diagnosed with obstructive sleep apnoea syndrome. Wefound that the decision board was valid. Reliability was excellent(j = 0.94). Concerning acceptability, 72% of the patients were satisfied with the information provided in the decision board and 71% indicated that it helped them to make a decision. The average score of true ⁄ false test of knowledge was 7.9 of 10 (range 3–10). The decision board we developed is a valid, reliable and acceptable tool to assess patients preferences.

U2 - 10.1111/j.1365-2869.2012.01015.x

DO - 10.1111/j.1365-2869.2012.01015.x

M3 - Article

VL - 21

SP - 577

EP - 583

JO - Journal of Sleep Research

JF - Journal of Sleep Research

SN - 0962-1105

IS - 5

ER -